Global Iron Sucrose Injection Market Overview:
The iron sucrose injections (Venofer) are iron replacement called ferric hydroxide sucrose, it is prescribed to the patients with chronic kidney disease (CKD) who lacks iron in the blood this problem is known as anemia. Without the sufficient amount of iron in the body, the creation of enough red blood cells diminishes which makes one unhealthy and results in iron deficiency called anemia. Iron sucrose injections are given either intravenously or into a dialysis line by a doctor in hospitals, clinics or in a dialysis treatment center. Some of the key players profiled in the study are American Regent Inc. (United States), AMAG Pharmaceuticals, Inc (United States), Daiichi Sankyo Company (Japan), International Brands (Pvt) Limited (SEARLE Company) (Pakistan), Shanghai Fosun Pharmaceutical Co., Ltd., (China), Nanjing Pharmaceutical Co., Ltd. (LifeEnergy) (China) and Opocrin S.p.A. (Italy).
On the basis of geography, the market of Iron Sucrose Injection has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channels, the sub-segment i.e. Online Pharmacy will boost the Iron Sucrose Injection market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Iron Sucrose Injection market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Packaging Size, the sub-segment i.e. 50 mg/2.5 mL will boost the Iron Sucrose Injection market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- The Rising Cases of Iron Deficiency called Anemia in Many People Resulting in Depletion of Health
- Growing Patients with Chronic Kidney Diseases Across the World
Market Trend
- Continuous Research Activities Happening on Iron Sucrose Injection
- The introduction of Iron Sucrose Injection Packages in Various Dosages
Restraints
- Allergic Reaction Involved with Iron Sucrose Injections
- Stringent Regulatory Standards on Iron Sucrose Injection
Opportunities
- Awareness about the Iron Deficiency Problems ill Boost the Iron Sucrose Injection Market
- Increasing Online Presence of Iron Sucrose Injection
Challenges
- Less awareness about Iron Sucrose Injections and its Benefits
"The FDA has approved ferric derisomaltose (Monoferric, Pharmacosmos Therapeutics Inc.) injection 100 mg/mL, according to a press release. Ferric derisomaltose is an intravenous iron for the treatment of iron deficiency anemia (IDA) in adult patients.his approval is based on safety and efficacy data from 2 clinical trials which included 3050 patients with IDA of different etiologies. The first trial (FERWON-IDA) included patients with IDA who had an intolerance to oral iron or who had unsatisfactory response to oral iron or for whom there was a clinical need for the rapid depletion of iron stores. The second trial, known as FERWON-NEPHRO, included patients with IDA who had non-dialysis dependent chronic kidney disease. For both trials, patients were randomized to treatment with ferric derisomaltose or iron sucrose over 8 weeks. Ferric derisomaltose was intravenously administered as a single dose of 1000 mg."
Iron Sucrose Injection market has very few players in the market because of its recent emergence and slow regulatory approval. The companies are trying to expand their product portfolio through continuous research and development on their products as to how to enhance the product on the basis of packaging size dosages and making it more effective.
Target Audience:
Iron Sucrose Injection Manufacturers, Iron Sucrose Injection International Traders, Iron Sucrose Injection Distributors and Suppliers, Research and Development Institutes, Potential Investors, Regulatory Bodies, Upstream and Downstream Buyers and Others
Major Objectives Focused through this Study
To define, describe, and forecast the Global Iron Sucrose Injection market on the basis of product [] , application [Adult, Adolescents, Geriatric and Children], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Iron Sucrose Injection market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Iron Sucrose Injection industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are .
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Iron Sucrose Injection market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.